Beijing SL Pharmaceutical Co Ltd (002038) — Cash Flow Quality Index
Beijing SL Pharmaceutical Co Ltd (002038) has a Cash Flow Quality Index of 3.32x as of September 2025. Operating cash flow of CN¥66.55 Million exceeds net income of CN¥20.05 Million, indicating high earnings quality where cash backs reported profits. Explore Beijing SL Pharmaceutical Co Ltd cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Beijing SL Pharmaceutical Co Ltd Cash Flow Quality Index (2003–2023)
Historical Cash Flow Quality Index for Beijing SL Pharmaceutical Co Ltd across 21 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Beijing SL Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Beijing SL Pharmaceutical Co Ltd (2003–2023)
Year-by-year earnings quality comparison for Beijing SL Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 002038 market cap overview.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 1.10x | CN¥460.20 Million | CN¥416.69 Million | ▼ -33.6% |
| 2022 | 1.66x | CN¥389.82 Million | CN¥234.40 Million | ▲ +52.5% |
| 2021 | 1.09x | CN¥464.63 Million | CN¥425.94 Million | ▼ -5.2% |
| 2020 | 1.15x | CN¥415.84 Million | CN¥361.45 Million | ▼ -17.1% |
| 2019 | 1.39x | CN¥665.83 Million | CN¥479.50 Million | ▲ +61.2% |
| 2018 | 0.86x | CN¥485.17 Million | CN¥563.39 Million | ▲ +19.6% |
| 2017 | 0.72x | CN¥380.72 Million | CN¥528.76 Million | ▼ -18.8% |
| 2016 | 0.89x | CN¥396.86 Million | CN¥447.39 Million | ▲ +1.4% |
| 2015 | 0.87x | CN¥504.87 Million | CN¥577.22 Million | ▲ +31.9% |
| 2014 | 0.66x | CN¥465.00 Million | CN¥701.05 Million | ▲ +9.2% |
| 2013 | 0.61x | CN¥347.41 Million | CN¥572.01 Million | ▼ -26.9% |
| 2012 | 0.83x | CN¥398.60 Million | CN¥479.98 Million | ▲ +90.5% |
| 2011 | 0.44x | CN¥228.59 Million | CN¥524.39 Million | ▼ -49.4% |
| 2010 | 0.86x | CN¥238.13 Million | CN¥276.39 Million | ▲ +20.4% |
| 2009 | 0.72x | CN¥174.41 Million | CN¥243.75 Million | ▼ -19.6% |
| 2008 | 0.89x | CN¥194.32 Million | CN¥218.43 Million | ▲ +35.7% |
| 2007 | 0.66x | CN¥88.36 Million | CN¥134.82 Million | ▼ -42.7% |
| 2006 | 1.14x | CN¥57.55 Million | CN¥50.34 Million | ▼ -18.5% |
| 2005 | 1.40x | CN¥47.48 Million | CN¥33.84 Million | ▲ +43.6% |
| 2004 | 0.98x | CN¥31.26 Million | CN¥31.99 Million | ▼ -0.2% |
| 2003 | 0.98x | CN¥30.55 Million | CN¥31.20 Million | — |